0000000000148611

AUTHOR

Anna Maria Barbui

showing 3 related works from this author

Zygomycosis in Italy: A survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)

2009

Abstract The aims of the study were to analyze the clinical and epidemiological characteristics and treatments for patients who developed zygomycosis enrolled in Italy during the European Confederation of Medical Mycology of medical mycology survey. This prospective multicenter study was performed between 2004 and 2007 at 49 italian Departments. 60 cases of zygomycosis were enrolled: the median age was 59.5 years (range 1-87), with a prevalence of males (70%). The majority of cases were immunocompromised patients (42 cases, 70%), mainly hematological malignancies (37). Among non-immunocompromised (18 cases, 30%), the main category was represented by patients with penetrating trauma (7/18, 3…

AdultMalemedicine.medical_specialtyAdolescentEpidemiologyAntifungal drugImmunocompromised HostPharmacotherapyZygomycosisDrug Resistance FungalAmphotericin BInternal medicineEpidemiologymedicineHumansPharmacology (medical)ChildMycosisAgedPharmacologyImmunocompromised hostAged 80 and overbusiness.industryMortality rateMucormycosisInfantEpidemiology; Immunocompromised host; ZygomycosisMiddle Agedmedicine.diseaseSurgeryInfectious DiseasesOncologyItalyChild PreschoolFemaleZygomycosisbusinessmedicine.drug
researchProduct

Cocirculation of Hajj and non-Hajj strains among serogroup W meningococci in Italy, 2000 to 2016

2019

In Italy, B and C are the predominant serogroups among meningococci causing invasive diseases. Nevertheless, in the period from 2013 to 2016, an increase in serogroup W Neisseria meningitidis (MenW) was observed. This study intends to define the main characteristics of 63 MenW isolates responsible of invasive meningococcal disease (IMD) in Italy from 2000 to 2016. We performed whole genome sequencing on bacterial isolates or single gene sequencing on culture-negative samples to evaluate molecular heterogeneity. Our main finding was the cocirculation of the Hajj and the South American sublineages belonging to MenW/clonal complex (cc)11, which gradually surpassed the MenW/cc22 in Italy. All M…

0301 basic medicineSerotypeMaleCefotaximeinvasive bacterial infectionsEpidemiologymolecular methodsNeisseria meningitidismedicine.disease_causeDisease Outbreaks0302 clinical medicineGenotypemolecular method030212 general & internal medicinenational surveillance systemChildPhylogenyAged 80 and overSurveillanceNeisseria meningitidisitaly; neisseria meningitidis; capsular serogroup w; clonal complex 11; invasive bacterial infections; invasive meningococcal disease; molecular methods; national surveillance systeminvasive bacterial infectionMiddle Aged3. Good healthItalyChild PreschoolPopulation SurveillanceFemalePublic Healthmedicine.drugAdultAdolescentAntibiotic sensitivity030106 microbiologyBiologySerogroup03 medical and health sciencesYoung AdultNeisseria meningitidis Serogroup W-135VirologymedicineNeisseria meningitidiHumanscapsular serogroup WAgedWhole Genome Sequencinginvasive meningococcal diseaseEnvironmental and Occupational HealthPublic Health Environmental and Occupational HealthInfant NewbornInfantSequence Analysis DNAVirologyPenicillinMeningococcal Infectionsclonal complex 11capsular serogroup W; clonal complex 11; invasive bacterial infections; invasive meningococcal disease; Italy; molecular methods; national surveillance system; Neisseria meningitidis; Epidemiology; Public Health Environmental and Occupational Health; VirologyHajjRifampicin
researchProduct

Successful Treatment of Suspected Donor-derived Human Herpesvirus-8 Infection in a Liver Transplant Patient With Coronavirus Disease-19

2021

Transplantationbusiness.industrymedicine.medical_treatmentcoronavirus disease-19DiseaseLiver transplantationmedicine.disease_causemedicine.diseaseVirologyliver transplantHerpesviridae InfectionsCytokine release syndromehuman herpesvirus-8CarcinomaMedicineRituximabTransplant patientbusinessmedicine.drugCoronavirusTransplantation
researchProduct